Reuters logo
BRIEF-Argentum Pharmaceuticals, Allergan settle patent dispute over Restasis
April 18, 2017 / 8:13 PM / 5 months ago

BRIEF-Argentum Pharmaceuticals, Allergan settle patent dispute over Restasis

April 18 (Reuters) - Allergan Plc

* Argentum PHARMACEUTICALS and Allergan settle patent dispute over Restasis

* Argentum Pharmaceuticals - specific date on which Argentum may launch generic product and other details concerning settlement have not been disclosed

* Argentum Pharmaceuticals- agreement generally provides Argentum may commence marketing generic equivalent product sometime prior to expiration of patents covering Restasis Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below